Clinical Trials

MabVax Therapeutics , a clinical-stage biotechnology company that aims to develop antibody-based products to address unattainable medical needs to treat cancer declared positive results…
Read More...

Median Technologies, the industry-leading Imaging Phenomics Company and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development,…
Read More...

ENYO Pharma SA declared that it is strengthening its leadership team with the appointment of a VP Non-Clinical Development & Product Profiling. ENYO Pharma also confirms that its…
Read More...

Celltex Therapeutics Corporation asserted its authorization to conduct an investigational protocol which is a Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and…
Read More...

Abbott and Surmodics proclaimed having forayed into an agreement wherein Abbott will possess exclusive commercialization rights for Surmodic's Surveil drug-coated balloon to treat the…
Read More...

Longeveron asserted that its revolutionary Clinical Trial initiated to treat infants with Hypoplastic Left Heart Syndrome as the first patient received the treatment using the company's…
Read More...

Eli Lilly and Company proclaimed that the USFood and Drug Administration has sanctioned Verzenio (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based…
Read More...

PharmaCyte Biotech aiming to develop targeted cellular therapies for Cancer and diabetes using its signature  live-cell encapsulation technology, Cell-in-a-Box, announced that its…
Read More...

Leading Science and technology company, Merck announced that the Argentinian Administration of Medicines, Food and Medical Technology has sanctioned the registration of MAVENCLAD …
Read More...

Jazz Pharmaceuticals asserted the enrollment of patients in a Phase 2 Clinical Trial evaluating the efficacy and safety of defibrotide for the prevention of acute…
Read More...

Kadmon Holdings claimed positive results from ongoing Phase 2 Clinical trial KD025-208 assessing updated optimistic results from an ongoing Phase 2 Clinical Trial KD025-208 evaluating…
Read More...

Vertex Pharmaceuticals affirmed initiating the first Phase 3 study of VX-659,  tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis…
Read More...

Achieve Life Sciences which is a clinical-stage pharmaceutical company devoted to the global development and commercialization of cytisine ensuring routing smoking or terminating…
Read More...

KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. It is to be noted that Fractalkine receptor is an immunomodulating factor termed as …
Read More...

Catheter Precision Inc. asserted the launch of a pivotal Clinical Trial to evaluate the safety and accuracy of the VIVO Non-Invasive Mapping system. The VIVO system is designed to…
Read More...

Micromedic Technologies declared successful results of a Clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect technology. The study…
Read More...

Clinical-stage biopharmaceutical company,Wize Pharma aiming to undertake treatment of opthalmic disorders asserted having received Institutional Review Board approval for the protocol…
Read More...

Evolus asserted the presentation of data from the Phase III comparative Clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American…
Read More...

Optimal Research, a patient identification and trial activation service provider, and OncoLens, a software as a service (SaaS) tumor board solution asserted to partner to bring…
Read More...

Non-profit organization, Aeras committed to developing vaccines against TB declared results from breakthrough Clinical Trial aiding evidence that TB Vaccines could forbid sustained…
Read More...